TearSolutions
Charlottesville
About TearSolutions
TearSolutions is a pharmaceutical company that specializes in providing medical solutions for dry eyes. The company is driven by its mission is to develop a novel replacement therapy for dry eye through phase II human clinical trials. The platform technology is centered on the remarkable tear protein and the proprietary drug 'Lacripep'. An outsourcing model will be used.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $24.6M
- Last round: Series Unknown (Nov 2025)
- Website: tearsolutions.com
- Phone: 4349823912
Industries & Categories
Eyewear, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/tearsolutions-88157 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.